Devices › Device types
FDA product code QHM · class U · Microbiology
Serology tests used for infectious disease screening of blood and plasma donations: medical device reports filed with FDA
527 reports carry this product code, 2019–2026; 2 brands with a page.
- 527
- reports with this product code
- 0% of all MAUDE reports
- 60
- reports, 12 months to August 2026
- 42 in the 12 months before
- 76.3%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code QHM is FDA's classification for "Serology tests used for infectious disease screening of blood and plasma donations" (microbiology panel), a class U device. 527 medical device reports carry this product code, 0% of the MAUDE database, from September 2019 to July 2026.
60 reports arrived in the 12 months to August 2026, up 43% from 42 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (76.3%) and injury (23.7%). 2 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Prism Hcv | 5 | 0 | 0% | 68.8% |
| Elecsys HIV Duo | 1 | 300 | 0% | 100% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Abbott | 241 | 45.7% |
| Abbott Ireland | 90 | 17.1% |
| Abbott Ireland Diagnostics Division | 35 | 6.6% |
| Abbott Laboratories | 24 | 4.6% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| False positive result | 471 | 89.4% |
| False negative result | 51 | 9.7% |
| Non reproducible results | 4 | 0.8% |
| High test results | 2 | 0.4% |
| Incorrect, inadequate or imprecise result or readings | 2 | 0.4% |
| Leak/splashthe device leaked | 2 | 0.4% |
| Low test results | 1 | 0.2% |
Questions about serology tests used for infectious disease screening of blood and plasma donations reports
What is product code QHM?
FDA's classification code for "Serology tests used for infectious disease screening of blood and plasma donations", class U, reviewed by the microbiology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
527 reports through August 2026, 60 of them in the latest 12 months.
Which brands appear most often?
Prism Hcv (5) and Elecsys HIV Duo (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.